IntelliAM aiming for significant growth with £5 million Aquis IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 604.50
Bid: 606.00
Ask: 606.50
Change: 2.50 (0.42%)
Spread: 0.50 (0.083%)
Open: 604.00
High: 608.00
Low: 600.00
Prev. Close: 602.00
TATE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update to the Notice of AGM 2024

21 Jun 2024 14:45

RNS Number : 4481T
Tate & Lyle PLC
21 June 2024
 

Tate & Lyle PLC

 

Update to the Notice of Annual General Meeting 2024

 

Further to our announcement on 4 June 2024 (1075R) of the publication of our Annual Financial Report and Notice of Annual General Meeting 2024, Tate & Lyle PLC ('the Company' or 'Tate & Lyle') announces that it will seek approval for an additional resolution at the Annual General Meeting and has submitted a revised Proxy Form to shareholders for this purpose. The revised Proxy Form has also been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism

 

Proxy Form - http://www.rns-pdf.londonstockexchange.com/rns/4481T_1-2024-6-21.pdf

 

This revised form of proxy is being sent to shareholders further to the announcement on 20 June 2024 of the proposed combination of the Tate & Lyle and CP Kelco businesses. A copy of our announcement of this transaction can be found at our website: www.tateandlyle.com. 

 

The Proposed Transaction constitutes a Class 1 transaction for Tate & Lyle under the UK Listing Rules and is, therefore, as at the date of this letter, conditional on the approval of Tate & Lyle's shareholders. As indicated by the Financial Conduct Authority ("FCA"), the UK Listing Rules are expected to change in the coming weeks, such that the requirement for a shareholder meeting to vote to approve a Class 1 transaction would no longer apply.  

 

At the present time, Tate & Lyle requires the permission of its shareholders at a general meeting to change the name of the Company. In contemplation of the changes to the Listing Rules as set out above, the Board proposes to amend the Company's Articles of Association to permit the directors to change the name of the Company should the Directors consider this to be appropriate following the combination with CP Kelco.

  

Accordingly, the Directors have reissued the proxy card for the above AGM with an additional resolution seeking shareholder approval for this proposed amendment to the Articles. 

 

It is proposed that the following resolution be passed as a special resolution: 

 

Resolution 23: to add a new Article 127 to the Articles of Association as follows:  

127 CHANGE OF NAME The Company may change its name by resolution of the board. 

 

Accordingly, shareholders should submit, or, if they have already voted, resubmit their votes using the revised form of proxy 

 

The Annual General Meeting 2024 will be held at the Royal College for Nursing, 20 Cavendish Square, London, W1G 0RN at 10.30am on 25 July 2024.

 

The Annual Report 2024, Notice of Annual General Meeting 2024, Notice of Availability, and Proxy Form are also available on the Company's website: https://www.tateandlyle.com/news/2024-annual-report-and-notice-agm. Mailing of the Annual Report 2024, Notice of Annual General Meeting 2024, Notice of Availability and Proxy Form to shareholders who have requested or are entitled to receive them will occur shortly.

 

We will notify shareholders of any significant updates to our Annual General Meeting 2024 arrangements via a regulatory information service and on the Investors Hub section of the Company's website.

 

Claire-Marie O'Grady

Company Secretary

21 June 2024

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMGZGZVFMZGDZM
Date   Source Headline
4th Jul 20245:40 pmRNSTransaction in Own Shares
3rd Jul 20245:29 pmRNSTransaction in Own Shares
2nd Jul 20245:32 pmRNSTransaction in Own Shares
2nd Jul 202411:30 amRNSHolding(s) in Company
1st Jul 20245:29 pmRNSTransaction in Own Shares
1st Jul 202412:30 pmRNSTotal Voting Rights
28th Jun 20245:59 pmRNSTransaction in Own Shares
27th Jun 20245:37 pmRNSTransaction in Own Shares
27th Jun 20244:30 pmRNSCompletes sale of remaining interest in Primient
27th Jun 20243:30 pmRNSHolding(s) in Company
26th Jun 20245:38 pmRNSTransaction in Own Shares
25th Jun 20245:50 pmRNSTransaction in Own Shares
24th Jun 20245:35 pmRNSTransaction in Own Shares
24th Jun 20243:30 pmRNSHolding(s) in Company
21st Jun 20245:45 pmRNSTransaction in Own Shares
21st Jun 20242:45 pmRNSUpdate to the Notice of AGM 2024
20th Jun 20246:03 pmRNSTransaction in Own Shares
20th Jun 20247:05 amRNSLaunch of Share Buyback
20th Jun 20247:00 amRNSCombination of Tate & Lyle and CP Kelco
4th Jun 20245:22 pmRNSAnnual Financial Report and Notice of AGM
4th Jun 202411:00 amRNSDirector/PDMR Shareholding
3rd Jun 202412:00 pmRNSTotal Voting Rights
30th May 202412:15 pmRNSHolding(s) in Company
23rd May 20247:00 amRNSFinal Results
23rd May 20247:00 amRNSSale of remaining interest in Primient JV to KPS
20th May 20241:00 pmRNSDirectorate Change
17th May 20243:30 pmRNSHolding(s) in Company
14th May 20243:30 pmRNSHolding(s) in Company
13th May 202410:00 amRNSHolding(s) in Company
8th May 20243:15 pmRNSHolding(s) in Company
1st May 20242:30 pmRNSTotal Voting Rights
25th Apr 20243:45 pmRNSHolding(s) in Company
24th Apr 20247:00 amRNSDirectorate Change
22nd Apr 20242:30 pmRNSDirector/PDMR Shareholding
19th Apr 202410:15 amRNSHolding(s) in Company
17th Apr 20244:15 pmRNSHolding(s) in Company
17th Apr 202410:30 amRNSHolding(s) in Company
15th Apr 202410:30 amRNSHolding(s) in Company
10th Apr 20243:45 pmRNSHolding(s) in Company
8th Apr 202411:15 amRNSHolding(s) in Company
5th Apr 20243:45 pmRNSHolding(s) in Company
4th Apr 20244:15 pmRNSHolding(s) in Company
4th Apr 202412:30 pmRNSHolding(s) in Company
4th Apr 202411:30 amRNSDirector/PDMR Shareholding
2nd Apr 202412:45 pmRNSTotal Voting Rights
2nd Apr 202411:30 amRNSHolding(s) in Company
28th Mar 202411:45 amRNSHolding(s) in Company
25th Mar 202411:45 amRNSHolding(s) in Company
21st Mar 20244:10 pmRNSHolding(s) in Company
20th Mar 20243:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.